Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.

× No keyword cloud information.

5 in total

1. Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Authors: S Martino; B A Samal; B Redman; L Flaherty; M Kraut; M Simon; M Valdivieso
Journal: Breast Cancer Res Treat Date: 1990-12 Impact factor: 4.872

2. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).

Authors: H Hochster; M Hunt; M Green; D Parkinson; T Smith
Journal: Invest New Drugs Date: 1990-08 Impact factor: 3.850

3. Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach.

Authors: G Somlo; J Doroshow; S Akman; L Leong; K Margolin; M McNamara; P Multhauf; D Blayney; R Morgan; J Raschko
Journal: Invest New Drugs Date: 1991-02 Impact factor: 3.850

4. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.

Authors: W P McGuire; J A Blessing; M L Berman
Journal: Invest New Drugs Date: 1989-11 Impact factor: 3.850

5. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

Authors: W P McGuire; J A Blessing; E Yordan; J Beecham
Journal: Invest New Drugs Date: 1989-07 Impact factor: 3.850

5 in total